Bai, Ming

Gemcitabine plus S-1 versus cetuximab as a third-line therapy in metastatic colorectal cancer: an observational trial. [electronic resource] - International journal of clinical and experimental medicine 2015 - 21159-65 p. digital

Publication Type: Journal Article

1940-5901